Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BG Medicine       

BG MEDICINE
Mes dernières consult.
Most popular
Report
SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

BG Medicine, Inc. : Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/08/2013 | 01:22pm CET

TRENTON, N.J. and WALTHAM, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- The Trenton Health Team (THT) and BG Medicine (Nasdaq:BGMD) today announced that THT has adopted the BGM Galectin-3® test throughout its organization to identify patients at near term risk for heart failure rehospitalization. THT is a community health improvement collaborative that serves the six zip codes of Trenton, New Jersey and is in the process of developing a Medicaid accountable care organization (ACO).

Reducing unplanned readmissions for patients continues to be one of the most urgent and pressing issues facing hospitals in the U.S. today, particularly since October 2012, when the federal (CMS) enacted new rules that impose significant financial penalties on hospitals with excessive 30-day hospital readmission rates. Among the heart failure population, hospital readmissions can approach up to 25% within 30 days, putting a substantial economic and emotional burden on patients and families, while costing the healthcare system billions of dollars.

"As a collaborative looking to develop an accountable care organization, we are always looking for products and programs that can deliver better quality healthcare while reducing overall costs. THT is committed to reducing unplanned hospital readmissions across the board by 15% in 2013, and the Galectin-3 diagnostic blood test should help us make an impact on readmission rates in one of the most costly patient populations-chronic heart failure patients," stated Dr. Robert Remstein, the President of THT and Vice President for accountable care at Capital Health. "This test can assist our urban based clinicians in identification of patients with heart failure at highest risk for poor outcomes, and guide them towards cost effective care that will improve outcomes and lower overall health care costs."

"Measuring Galectin-3 levels is a simple way to identify patients who are at higher risk of poor outcomes resulting from cardiovascular disease leading to unplanned readmission," stated Eric Bouvier, President and CEO of BG Medicine. "The Trenton Healthcare Team is leading the charge by adopting a broad scope of efforts to reduce costly hospital readmissions."

About Galectin-3 Testing

Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure. Higher levels of galectin-3 are associated with a more aggressive form of heart failure, which may make identification of high-risk patients using galectin-3 testing an important part of patient care. Galectin-3 testing may be useful in helping physicians determine which patients are at higher risk of death or hospitalization, including 30-day readmission. www.galectin-3.com

About BG Medicine, Inc.

BG Medicine, Inc. (Nasdaq:BGMD) is a diagnostics company focused on the development and commercialization of novel cardiovascular tests to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company has two products: the BGM Galectin-3® test for use in patients with chronic heart failure is available in the United States and Europe; and the CardioSCORE™ test for the risk prediction of major cardiovascular events is expected to be launched in Europe in the first half of 2013. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com and www.galectin-3.com.

About the Trenton Health Team

Trenton Health Team (THT) is an alliance of the city's major providers of healthcare services including Capital Health, St. Francis Medical Center, Henry J. Austin Health Center and the city's Health Department. In collaboration with residents and the city's active social services network, THT is developing an integrated healthcare delivery system to transform the city's fragmented primary care system and restore health to the city. THT aims to make Trenton the healthiest city in the state. The THT receives generous support from The Nicholson Foundation, corporate partners and other foundations. For more information, visit www.trentonhealthteam.org.

About Accountable Care Organizations

Accountable care organizations (ACOs) are groups of doctors, hospitals, and other health care providers, who come together voluntarily to give coordinated high quality care to the Medicare patients they serve. Coordinated care helps ensure that patients, especially the chronically ill, get the right care at the right time, with the goal of avoiding unnecessary duplication of services and preventing medical errors. When an ACO succeeds in both delivering high-quality care and spending health care dollars more wisely, it will share in the savings it achieves for the Medicare program.

CONTACT: Media Contacts:


         For BG Medicine: Charles Liles,

         MacDougall Biomedical Communications, (781) 235-3060


         For THT: Becky Taylor, [email protected], (609) 240-6886


         BG Medicine Investor Inquiries:


         Chuck Abdalian, EVP & Chief Financial Officer, (781) 434-0210
Source: BG Medicine Inc.

News Provided by Acquire Media

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BG MEDICINE
2015 BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional I..
2015 BG MEDICINE : Announces Business Update Conference Call Information
2015 BG MEDICINE : License and Distribution Agreement Amended
2015 BG MEDICINE : Reports Third Quarter 2015 Financial Results
2015 License and Distribution Agreement Amended
2015 BG Medicine Reports Third Quarter 2015 Financial Results
2015 BG Medicine Announces Business Update Conference Call Information
2015 BG MEDICINE, INC. : BG Medicine Due Diligence Report: Quietly Making Headway - ..
2015 BG Medicine to Begin Trading on the OTCQB
2015 BG Medicine Provides Business Update and Reports Second Quarter 2015 Financia..
More news
News from SeekingAlpha
2015 Midday Gainers / Losers
2015 BG MEDICINE REVERSE SPLITS STOCK 1 : 4 effective today
2015 BG Med's largest customer bankrupt but galectin-3 purchases continue (for now..
2015 BG MEDICINE : A Takeover Target?
2015 BG Medicine's (BGMD) CEO Paul Sohmer on Q1 2015 Results - Earnings Call Trans..
Income Statement Evolution
Managers
NameTitle
Paul R. Sohmer President, Chief Executive Officer & Director
Harry W. Wilcox Chairman
Stephen P. Hall Chief Financial Officer, Treasurer & EVP
Aram S. Adourian Chief Scientific Officer & Senior Vice President
Stelios B. Papadopoulos Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BG MEDICINE0
JOHNSON & JOHNSON21.53%383 877
NOVARTIS12.01%221 304
PFIZER10.04%218 400
ROCHE HOLDING LTD.3.40%210 833
MERCK AND COMPANY-6.96%155 214